Mobile stroke unit roughly halves time to diagnosis and treatment of patients with suspected stroke

April 10, 2012

Using a specialised ambulance or mobile stroke unit (MSU) to assess and treat patients who have had a suspected stroke at the site of the emergency roughly halves the time from the initial call for help to treatment decision, and could increase the number of patients eligible for life-saving treatment, according to results of a study published Online First in The Lancet Neurology.

"The MSU strategy offers a potential solution to the medical problem of the arrival of most at the too late for treatment…and substantially breaks, to our knowledge, all reported times or management", explains Klaus Fassbender from the University of the Saarland, Homburg, Germany, lead author of the study.

Currently, the only treatment for acute ischemic stroke (in which blood flow to an area of the brain is blocked or reduced) is thrombolysis using the clot-busting drug alteplase (recombinant tissue plasminogen activator) within 4.5 hours of symptom onset. Patients must have computed tomography (CT) scans of the brain before treatment begins to confirm that a clot is the cause of the stroke. Fewer than 15% to 40% of patients arrive at the hospital early enough for treatment, and only an estimated 2% to 5% of eligible patients actually receive thrombolysis.

In this study, 100 patients with a suspected stroke were randomly assigned to receive either treatment before they reached hospital in a MSU equipped with a CT scanner, point-of-care laboratory, and telemedicine (53 patients) or optimised standard hospital-based stroke treatment (47 patients).*

Prehospital treatment substantially reduced the median time from alarm (emergency call) to therapy decision compared with hospital care (35 min vs 76 min). The MSU also lowered the time from symptom onset to therapy decision time to less than an hour for 57% of patients compared with just 4% in the hospital-care group.

Additionally, the time from alarm to thrombolysis was also substantially shorter in the MSU group (38 min vs 73 min).

The authors say: "According to the generally accepted 'time is brain' concept, such a large reduction in delay should translate into improved outcome...although in secondary analyses no significant difference was recorded in the numbers of patients who received thrombolysis or in neurological outcome."

They conclude: "Although the effect on clinical outcome needs further study in larger (eg, multicentre) trials, the results of this first randomised trial of the MSU strategy of bringing the hospital to the patient with stroke show that guideline-adherent diagnosis and therapy can be reliably delivered within the first 35 min after alarm, thus speeding up acute stroke management."

In an accompany Comment, Peter Rothwell and Alastair Buchan from Oxford University, UK, say: "The generalisability of the trial findings to potential MSU services elsewhere will depend very much on the setting. This trial was set in an urban area with a median distance from the patient to the hospital of 7km and median alarm to arrival times of 8 minutes for the standard versus 12 minutes for the MSU. The MSU would potentially work less well in rural areas in which locally based ambulances might be able to get to hospital about as quickly as a hospital-situated MSU could get out to the patient. Nevertheless, this trial has shown convincingly that in at least some settings an MSU-based service is feasible and can substantially reduce delays to treatment.

Explore further: Clot-busting drugs appear safe for treating 'wake-up' stroke patients

More information: *The trial was stopped early after a planned interim analysis at 100 of 200 planned patients because prespecified criteria for study termination had been met.

Related Stories

Clot-busting drugs appear safe for treating 'wake-up' stroke patients

February 1, 2012
Clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2012.

Recommended for you

Gene therapy improved left ventricular and atrial function in heart failure by up to 25 percent

September 25, 2017
Heart function improved by up to 25 percent in a trial using gene therapy to reverse cardiac damage from congestive heart failure in a large animal model, Mount Sinai researchers report. This is the first study using a novel ...

Tension makes the heart grow stronger

September 25, 2017
By taking videos of a tiny beating zebrafish heart as it reconstructs its covering in a petri dish, scientists have captured unexpected dynamics of cells involved in tissue regeneration. They found that the depleted heart ...

Hospital mortality rates after heart attack differ by age

September 25, 2017
Outcomes for older patients hospitalized for a heart attack are often used as a measure of hospital quality for all patients. But a study led by Yale researchers shows that hospital mortality rates for older patients with ...

Laser device placed on the heart identifies insufficient oxygenation better than other measures

September 20, 2017
A new device can assess in real time whether the body's tissues are receiving enough oxygen and, placed on the heart, can predict cardiac arrest in critically ill heart patients, report researchers at Boston Children's Hospital ...

Metabolism switch signals end for healing hearts

September 19, 2017
Researchers have identified the process that shuts down the human heart's ability to heal itself, and are now searching for a drug to reverse it.

Beta blockers not needed after heart attack if other medications taken

September 18, 2017
A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhibitors and statins. The study is the first to challenge ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.